Monoaminergic dysregulation on diestrus-2 and estrus through high emotional reactivity

Pharmacology Biochemistry and Behavior

Volumn 60, Issue 1, 1998, Pages 285-291

  Sfikakis, Anastasia ^a   Papadopoulou Daifotis, Zeta ^a   Sfikaki, Maria ^a   Messari, Joan ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Diestrus; Dopamine; Emotional reactivity; Estrus; Proestrus; Relevance to premenstrual syndrome; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CORPUS STRIATUM; DIESTRUS; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; EMOTIONALITY; ESTRUS; ESTRUS CYCLE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHALAMUS; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PROESTRUS; RAT; SEROTONINERGIC SYSTEM; THYMUS; VAGINA SMEAR;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANXIETY; BIOGENIC MONOAMINES; CORPUS STRIATUM; DIESTRUS; DOPAMINE; EMOTIONS; ESTRUS; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; PREMENSTRUAL SYNDROME; PREOPTIC AREA; PROESTRUS; RATS; RATS, WISTAR; SEROTONIN; THYMUS GLAND;

ANIMALIA;

EID: 0032077323     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00566-2     Document Type: Article

References (53)

1. Aghajanian G. K., Rosecrans J. A., Sheard M. H. Serotonin release in the forebrain by stimulation of midbrain raphe. Science. 156:1967;402-403.
2. Akana S. F., Shinsako J., Dallman M. F. Relationships among adrenal weight, corticosterone and stimulated adrenocorticotropin levels in rats. Endocrinology. 113:1983;2226-2231.
3. Armario A., Restrepo C., Castellanos J. M., Balash J. Dissociation between adrenocorticotropin and corticosterone responses to restraint after previous chronic exposure to stress. Life Sci. 36:1985;2085-2092.
4. Azmitia E. C., McEwen B. S. Corticosteroid regulation of tryptophan hydroxylase in mid-brain of the rat. Science. 166:1969;1274-1276.
5. Baron S., Brush F. R. Effects of acute and chronic restraint and estrous cycle on pituitary-adrenal function in the rat. Horm. Behav. 12:1979;218-224.
6. Biegon A., Bercovitz H., Samuel D. Serotonin receptor concentration during the estrous cycle of the rat. Brain Res. 187:1980;221-225.
7. Bhattacharya S. K., Glover V., McIntyre I., Oxenkrug G., Sandler M. Stress causes an increase in endogenous monoamine oxidase inhibitor (tribulin) in rat brain. Neurosci. Lett. 92:1988;218-221.
8. Blundell J. E. Serotonin and feeding. Essman W. B. Serotonin in health and disease, vol. V. Clinical application:1979;403-450 Spectrum, New York.
9. 2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology. 31:1992;671-678.
10. Butcher R. L., Collins W. E., Fugo N. W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day oestrous cycle of the rat. Endocrinology. 94:1974;1704-1708.
11. Chrousos G. P., Gold P. W. The concepts of stress and stress system disorders. JAMA. 267:1992;1244-1252.
12. Compton M. M., Caron A. M., Cidlowski J. A. Glucocorticoid action on the immune system. J. Steroid Biochem. 27:1987;201-208.
13. Doherty M. D., Gatton A. High-speed chronamperometric measurements of mesolimbic and nigrostriatal dopamine release associated with repeated daily stress. Brain Res. 586:1992;295-302.
14. Dunn A. J., Berridge C. W. Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic system. Pharmacol. Biochem. Behav. 27:1987;685-691.
15. Ganong, W. F.: Review of medical physiology. 17th ed. Lange Medical Book, Prentice-Hall International; 1995:239.
16. Goudsmit E. M. Psychological aspects of premenstrual symptoms. J. Psychosom. Obstet. Gynaecol. 2:1983;20-26.
17. Halbreich U., Kas D. Variations in the Taylor MAS of women with premenstrual syndrome. J. Psychosom. Res. 21:1977;391-393.
18. Johnson S. R., McChesney C., Bean J. A. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J. Reprod. Med. 33:1988;340-346.
19. Kazandjian A., Spyraki C., Sfikakis A., Varonos D. Apomorphine-induced behaviour during the oestrous cycle of the rat. Neuropharmacology. 26:1987;1037-1045.
20. Khalid B. A. K., Lim A. T. W., Funder J. W. Steroid effects on protein synthesis. Mineral corticoids and glucocorticoids, thymus and pituitary. Int. Comp. Ser. 298:1983;289-294.
21. Lepage P., Steiner M. Gender and serotonergic dysregulation. Implications for late luteal phase dysphoric disorder Cassano G. B., Akiskal H. S. Serotonin-related psychiatric syndromes. Clinical and therapeutic links:1991;131-143 Royal Society of Medicine Services, London.
22. Luine V. N., McEwen B. S. Effect of oestradiol on turnover of type A monoamine oxidase in brain. J. Neurochem. 28:1977;1221-1227.
23. McEwen B. S., Parsons B. Gonadal steroid action on the brain neurochemistry and neuropharmacology. Annu. Rev. Pharmacol. Toxicol. 22:1982;555-598.
24. Moore K. E., Johnston C. A. The median eminence aminergic control mechanisms. Muller E. E., MacLeod R. M. Neuroendocrine perspectives, vol. 1. 1982;23-68 Elsevier Biomedical Press, Amsterdam.
25. Osterburg H. H., Telford N. A., Morgan D. G., Cohen-Becker L., Wise P. M., Finch C. E. Hypothalamic monoamines and their catabolites in relation to estradiol-induced luteinizing hormone surge. Brain Res. 409:1987;31-40.
26. Palkovits M. Topography of chemically identified neurons in the central nervous system; Progress in 1981-1983. Muller E., MacLeod R. Neuroendocrine perspectives, vol. 3. 1984;1-69 Elsevier, Amsterdam.
27. Papadopoulou-Daifotis Z., Antoniou K., Vamvakides A., Kalliteraki I., Varonos D. D. Neurochemical changes in dopamine and serotonin turnover rate in discrete regions of rat brain after the administration of glucinergic compounds. Acta Ther. 21:1995;5-18.
28. Papp M., Willner P., Muscat R. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology (Berlin). 110:1993;159-164.
29. Plotsky P. M., Cunningham E. T. J., Widmaier E. P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev. 10:1989;437-458.
30. Rabin D. S., Schmidt P. J., Campbell G., Gold P. W., Jensfold M., Rubinow D. R., Chrousos G. P. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. J. Clin. Endocrinol. Metab. 71:1990;1158-1162.
31. Rapkin A. J. The role of serotonin in premenstrual syndrome. Clin. Obstet. Gynecol. 35:1992;629-636.
32. Rivera-Tovar A. D., Frank E. Late luteal phase dysphoric disorder in young women. Am. J. Psychiatry. 147:1990;1634-1636.
33. Rojansky N., Halbreich U., Zander K., Barkai A., Goldstein S. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol. Obstet. Invest. 31:1991;146-152.
34. Rubinow D. R., Schmidt P. J. Premenstrual syndrome. A review of endocrine studies Endocrinologist. 2:1992;47-54.
35. Sampson D., Willner P., Muscat R. Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology (Berlin). 104:1991;491-495.
36. Schwartz N. B. Mechanisms controlling ovulation in small mammals. Greep R. O., Astwood E. B., Geiger S. R. Handbook of physiology, section 7. Endocrinology, vol II:1973;125-141 Am. Physiol Soc, Washington, DC.
37. Sfikakis A., Galanopoulou P., Konstandi M., Tsakayannis D. Stress through handling for vaginal screening, serotonin and ACTH response to ether. Pharmacol. Biochem. Behav. 53:1996;965-970.
38. Sfikakis A., Papadopoulou-Daifotis Z., Bikas N., Sakellariou A., Sfikaki M. Chronic and intense stress in relation to hypothalamic serotonergic system on diestrus-2 and proestrus. Neuropsychopharmacology. 9:1993;173S.
39. Sfikakis A., Spyraki C., Sitaras N., Varonos D. Implication of the estrous cycle on conditioned avoidance behavior in the rat. Physiol. Behav. 21:1978;441-446.
40. Shannon N. J., Gunnet J. W., Moore K. E. A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J. Neurochem. 47:1986;958-965.
41. Sharp T., Zetterstrom T., Series H. G., Carlsson A., Grahame-Smith D. G., Ungerstedt U. HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life Sci. 41:1987;869-872.
42. Siiteri P. K., Febres F. Ovarian hormone synthesis, circulation and mechanism of action. DeGroot L. J., Cahill G. F., Martini L., Nelson D. H., Odell W. D., Potts J. T., Steinberger E., Winegrad A. I. Endocrinology, vol. 3. 1979;1401-1417 Grune and Stratton, New York.
43. Simpson M. E., Evans H. M., Li C. H. Bioassay of adrenocorticotropic hormone. Endocrinology. 33:1941;261-268.
44. Steiner M. Female-specific mood disorders. Clin. Obstet. Gynecol. 35:1992;599-611.
45. Tartellini M. P., Gorski R. Variations in food and water intake in the normal and acyclic female rat. Physiol. Behav. 7:1971;847-852.
46. Ter Haar M. B. Circadian and estrual rhythm in food intake in the rat. Horm. Behav. 3:1972;213-219.
47. 1A agonist 8-OH-DPAT. Pharmacol. Biochem. Behav. 40:1991;901-906.
48. Vitale M. L., Villar M. J., Chiochio S. R., Tramezzani J. H. Dorsal raphe lesion alters the estrous cycle and the preovulatory gonadotropin release. Neuroendocrinology. 46:1987;252-257.
49. Watts S. F. F., Butt W. R., Logan Edwards R., Holder G. Hormonal studies in women with premenstrual tension. Br. J. Obstet. Gynaecol. 92:1985;247-255.
50. Willner P. Dopamine and depression. A review of recent evidence. II. Theoretical approaches Brain Res. Rev. 6:1983;225-236.
51. 1A receptor subsensitivity a trait marker for late luteal phase dysphoric disorder? A pilot study. Can. J. Psychiatry. 38:1993;662-664.
52. Yoshinaga K. Gonadotrophin-induced hormone secretion and structural changes in the ovary during the nonpregnant reproductive cycle. Greep R. O., Astwood E. B., Geiger S. R. Handbook of physiology, section 7. Endocrinology, vol. II:1973;363-388 Am. Physiol. Soc, Washington, DC.
53. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 44:1992;401-458.